Literature DB >> 28044261

Cognitive Development in a Young Child with Mucolipidosis Type IV: A Case Report.

Evelyn L Fisher1, Rose A Sevcik2, MaryAnn Romski2.   

Abstract

Mucolipidosis Type IV (ML IV) is an autosomal recessive genetic disorder characterized by severe psychomotor impairments and ophthalmologic abnormalities. Reports on the cognitive development of people with ML IV are limited, but suggest that achievement of language and cognitive milestones varies between a 3- and 18-month level. There is also variability in reports of whether people with ML IV make developmental progress, regress, or remain static after infancy. This study examines the longitudinal development of a young child with ML IV who participated in an augmentative and alternative communication (AAC) intervention.At 26 months, the child displayed significant developmental delays on direct assessment, with the exception of a possible relative strength in receptive language. An examination of adaptive behavior over time indicated improvements in raw scores but declines in standard scores across all domains. She learned to use 13 new words with a speech generating device (SGD) by the end of intervention.These results add to literature on the clinical manifestations of ML IV and indicate that although children with this disorder have deficits in many domains, they may be most severely affected in gross motor or oral motor development and have a relative strength in receptive language. Moreover, this child made progress in all domains of adaptive functioning, but at a slower pace than typically developing children. She also gained expressive vocabulary in the AAC intervention, and this may have supported her development in other areas.

Entities:  

Year:  2017        PMID: 28044261      PMCID: PMC5585098          DOI: 10.1007/8904_2016_31

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  10 in total

1.  Communication Services and Supports for Individuals With Severe Disabilities: Guidance for Assessment and Intervention.

Authors:  Nancy C Brady; Susan Bruce; Amy Goldman; Karen Erickson; Beth Mineo; Bill T Ogletree; Diane Paul; Mary Ann Romski; Rose Sevcik; Ellin Siegel; Judith Schoonover; Marti Snell; Lorraine Sylvester; Krista Wilkinson
Journal:  Am J Intellect Dev Disabil       Date:  2016-03

Review 2.  Early Intervention and AAC: What a Difference 30 Years Makes.

Authors:  MaryAnn Romski; Rose A Sevcik; Andrea Barton-Hulsey; Ani S Whitmore
Journal:  Augment Altern Commun       Date:  2015-07-08       Impact factor: 2.214

3.  Randomized comparison of augmented and nonaugmented language interventions for toddlers with developmental delays and their parents.

Authors:  MaryAnn Romski; Rose A Sevcik; Lauren B Adamson; Melissa Cheslock; Ashlyn Smith; R Michael Barker; Roger Bakeman
Journal:  J Speech Lang Hear Res       Date:  2010-04       Impact factor: 2.297

4.  Congenital corneal clouding with abnormal systemic storage bodies: a new variant of mucolipidosis.

Authors:  E R Berman; N Livni; E Shapira; S Merin; I S Levij
Journal:  J Pediatr       Date:  1974-04       Impact factor: 4.406

5.  Quantitative neuroimaging in mucolipidosis type IV.

Authors:  Raphael Schiffmann; Joan Mayfield; Caren Swift; Igor Nestrasil
Journal:  Mol Genet Metab       Date:  2013-11-21       Impact factor: 4.797

Review 6.  Mucolipidosis type IV: an update.

Authors:  Kazuyo Wakabayashi; Ann Marie Gustafson; Ellen Sidransky; Ehud Goldin
Journal:  Mol Genet Metab       Date:  2011-06-16       Impact factor: 4.797

7.  Mucolipidosis type IV: a subtle pediatric neurodegenerative disorder.

Authors:  Joseph S Geer; Steve A Skinner; Ehud Goldin; Kenton R Holden
Journal:  Pediatr Neurol       Date:  2010-03       Impact factor: 3.372

8.  Parent perceptions of the language development of toddlers with developmental delays before and after participation in parent-coached language interventions.

Authors:  MaryAnn Romski; Rose A Sevcik; Lauren B Adamson; Ashlyn Smith; Melissa Cheslock; Roger Bakeman
Journal:  Am J Speech Lang Pathol       Date:  2011-02-17       Impact factor: 2.408

Review 9.  Methods for assessing neurodevelopment in lysosomal storage diseases and related disorders: a multidisciplinary perspective.

Authors:  Holly R Martin; Michele D Poe; Debra Reinhartsen; Rebecca E Pretzel; Jackson Roush; Angela Rosenberg; Stacey C Dusing; Maria L Escolar
Journal:  Acta Paediatr       Date:  2008-04       Impact factor: 2.299

10.  Mucolipidosis type IV: clinical spectrum and natural history.

Authors:  N Amir; J Zlotogora; G Bach
Journal:  Pediatrics       Date:  1987-06       Impact factor: 7.124

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.